Seattle, WA /PRNewswire/ -- VentiRx Pharmaceuticals, Inc., a privately held biopharmaceutical company dedicated to the development of novel Toll-like receptor 8 (TLR8) agonists and antagonists today announced the formation of an exclusive, world-wide collaboration with Celgene Corporation (NASDAQ: CELG) for the development of VTX-2337, a highly potent and selective TLR8 agonist for the treatment of cancer. As part of the strategic agreement, Celgene will retain the exclusive option to acquire VentiRx.
Y-Prime Technologies Exhibiting Enterprise Content Management (ECM) and Cloud-Based Solutions at DIA/EDM Conference in Baltimore - MALVERN, PA, September 25, 2012 -- Y-Prime Technologies LLC, a premier eClinical products and consulting company, will highlight its growing Enterprise Content Management Practice, new products and its cloud-based solutions at the Drug Industry Association's EDM and ERS/eCTD Conference October 8-11 at the Hilton Baltimore. Y-Prime will be in Booth 311.
By bringing 5 of the leading clinical operations events under one roof, the Clinical Business Expo gives you everything you need to stay on top of new directions in drug development while you collaborate with CROs and niche service providers specializing in lab, data, sample and clinical supply chain management that would other-wise be difficult and time-consuming to meet in person.
Drug Delivery Technologies Show Promise of Improving Clinical Outcomes for Patients at PODD: Partnership Opportunities in Drug Delivery Conference
New York, NY — In an effort to remove barriers and embrace collaborations to get therapeutics to patients faster, pharmaceutical and biotech companies will listen to more than 25 drug delivery technology presentations, ranging from novel delivery devices to formulation technologies at the 2nd Annual PODD: Partnership Opportunities in Drug Delivery conference, October 1-2, 2012, at the Boston Park Plaza hotel in Boston, MA.
Life Science Industry Leaders Gather to Advance Global Clinical Outcomes
New York - The Conference Forum has announced that the 3rd Annual Executing Global Clinical Trial’s event will take place on September 13-14 at the Fairmont Copley Square Hotel in Boston, MA. “The trend to globalization creates opportunities and challenges for clinical trial management. To be successful, we must focus on quality, ethics, fair market value, logistics and culture,” says Dr Barbara Skinn, Director of Collaborative Science Center of Excellence at Bristol-Myers Squibb.
Research Triangle Park, N.C. – Glenn Veit, IRB chairperson at Copernicus Group IRB (CGIRB), a leading independent review board, was among the featured speakers at this month’s “Creating a Global Clinical Trial Platform: Partnering for Synergy” symposium in Durham, N.C..
Research Triangle Park, N.C. – Copernicus Group IRB (CGIRB), a leading independent institutional review board, today announced the selection of IRB Chairperson Glenn Veit as a speaker for the May 15 “Creating a Global Clinical Trial Platform” symposium. The event is sponsored by the Drug Information Association and the Duke Clinical Research Institute in collaboration with CGIRB.
Veit, a frequent industry speaker, and his co-panelists from Duke Medicine, Harvard University and Duke University Health System IRB, will discuss the practical implications and ethical considerations for multisite clinical trials conducted in a global setting during their session titled “Globalization of Clinical Research: Emerging Issues for Sponsors, Academic Research.” The panelists will provide strategies for sponsors, Academic Research Organizations and IRBs to work collaboratively to ensure the quality of global clinical trials.
Copernicus Group IRB (CGIRB) Quality Management Director Yvonne Higgins spoke at the Asia Pacific Research Ethics Conference, held March 7-9 at the Grand Copthorne Waterfront Hotel in Singapore.
Y-Prime Technologies LLC, a premier eClinical products and consulting company, is introducing two new software solutions, Prime eMVR™ and Prime IxR ™ that will optimize management and enhance performance of global clinical trials.
“For years, our consulting business has thrived providing high level integration and customization expertise leveraging our experience in both biopharmaceutical research and information technology,” explains Y-Prime CEO Shawn Blackburn. “Today, we are introducing the first two eClinical products that leverage these unparalleled capabilities providing smooth integration with existing systems, highly reliable data interchange and far-more efficient reporting tools that can save any biopharmaceutical company millions of dollars.”
Want more? Visit...